Introduction: Health care researchers and delivery system leaders share a common mission
| INTRODUCTION
Health care researchers and delivery system leaders share a common mission to improve health care quality and outcomes. A key goal for health services researchers, particularly for those embedded within learning health systems, is to improve health care by addressing delivery science research questions that are strategically important to health care organizations. Clinical and operational leaders also routinely work to improve care delivery through ongoing organizational quality improvement initiatives. However, despite these common interests, efforts to form research and operational partnerships may be hampered by a number of factors, including disparate priorities, timelines, and funding models. 1 Research funding models that are specifically designed to foster these partnerships and facilitate the translation of care innovations and knowledge into practice are still developing. 2 Traditional investigator-driven approaches to research may fail to adequately engage clinical and operational stakeholders, or create interventions that are not sustainable in real-world environments. 1 Research that is focused on understanding and addressing priorities within health care delivery systems may be more likely to lead to evidence-based innovations in processes and outcomes of care that can be diffused on a large scale. 3 Participatory research models that actively engage clinical and operational stakeholders in designing and conducting research have significant potential to increase the likelihood that research questions will be relevant to health care systems, and that research findings are translated quickly into systematic action. 4 Despite this need, there are no published accounts of research funding mechanisms specifically designed to encourage research and operational partnerships and put the findings of stakeholder-engaged research into action.
The Delivery Science Rapid Analysis Program (RAP), created in 2013, is an innovative funding mechanism designed to provide analytic and scientific resources to address rapidly researchable analytic questions with high value to both quality improvement leaders and researchers within Kaiser Permanente Northern California (KPNC). Figure 1 ). The RAP specifically targets the intersection of these 3 domains and focuses on identifying questions that meet the following criteria:
• Strategically relevant to TPMG (eg, provides information that helps meet quality goals)
• Covers a topic area and/or analytic method where a DOR scientist has relevant expertise
• Can be expressed as 1 to 2 research aims with testable hypotheses
• Can be primarily addressed using existing data sources (eg, electronic health record data)
• Addressable with analyses requiring~6 months to complete
• Will lead to a research product (eg, publication, abstract, pilot data for grant proposal)
Projects are specifically excluded if they require:
• Significant data outside of what is available through existing data sources
• Analysis that cannot be completed in~6 months
• Topic area or analytic expertise that is not available at DOR or QOS
| RAP structure
The goal of the RAP is to identify and complete 2 to 4 projects annually that are of high strategic value to both DOR and QOS. 
| Process for receiving and selecting RAP project concepts
The RAP Steering Committee with membership from both DOR and TPMG/QOS issues calls for proposals to assess project ideas for consideration. All proposals are submitted to the program's project manager, who then works with the RAP lead (Dr. Schmittdiel) to distribute the ideas to the Committee for discussion and review. Once a concept is reviewed by the committee, a vote decides whether it should go forward as an approved RAP research project based on the selection criteria outlined in Section 2.1. The committee also has the opportunity to suggest clarifications or modest revisions to the proposals to help them adhere as closely as possible to the program's objectives.
Once a project concept is approved, the DOR investigator serving as the individual project lead works with the RAP manager to obtain IRB approval. If the project is determined to be a quality improvement initiative not requiring IRB approval, this is noted. The pediatric obesity project provided critical information to the pediatric leadership team on redesigning their current strategies for obese pediatric patients and resulted in a manuscript. 5 The lupus project's results are being used to inform strategies to address care gaps in SLE and have prompted new strategies to increase telephone contact between patients and their rheumatologists. The RAP-sponsored work on identifying ENDS use is being used to identify and target interventions toward populations vulnerable to this form of nicotine use.
| Generating RAP project ideas
The following case study provides a description of our first RAP funded project and outlines the impact the project has had on regional quality improvement and measurement.
Case study: "Finding Opportunities to Reduce Disparities in Blood
Pressure Control: A Focus on Adequate Dosing of Thiazide Diuretics"
Despite notable improvements in cardiovascular disease management and outcomes in recent years, disparities in morbidity and mortality persist in the United States. [6] [7] [8] [9] An important challenge for health care systems is the identification of modifiable determinants of suboptimal blood pressure management among Blacks/African Americans.
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Thiazide diuretics may be especially effective in the control of hypertension and in the prevention of strokes among Black/African American patients. [12] [13] [14] However, strategies for promoting the use of these therapies at clinically effective doses in clinical practice are needed.
Using Richmond medical center as a test case, this 6-month collaborative project between DOR investigators, QOS leaders, and TPMG clinicians assessed the feasibility of a quality improvement project aimed at reducing disparities in blood pressure control through targeted clinical intensification with thiazide diuretics. The specific aims of the project were (1) to examine thiazide diuretic dosing in Richmond by race and ethnicity using univariate and bivariate analysis and (2) to evaluate the feasibility of integrating data on thiazide use and dosing among black patients into routine team quality reports to facilitate clinically appropriate treatment intensification.
We created an algorithm to identify patients eligible for clinical intensification of thiazide diuretics. Baseline data revealed that 90% of the subset of Black/African American patients with uncontrolled hypertension with no documented allergy to thiazide therapy were not being prescribed a thiazide or were being prescribed a submaximal dose of a thiazide. Over the course of 3 months, Black/African American patients in poor control at Richmond were targeted for clinical intensification using thiazide diuretics. We compared rates of thiazide diuretic treatment, defined as any use (non-dose specific) and whether patients already prescribed a thiazide diuretic were at the maximal dose, at the end of this 3-month pilot intervention to rates at baseline. 
| DISCUSSION
The RAP is a new, specific mechanism to actively identify rapid-cycle analytic questions of strategic interests to both research and operations groups within KPNC, stimulate collaborations between researchers and clinical leaders, and provide direct funding to researchers and programmers to conduct this work. In addition, as discussed in our case study above, the RAP program has facilitated region-wide quality improvement strategies that have had an organization-wide impact on efforts to improve hypertension care for Black/ African Americans patients. to adopt a similar model should be encouraged by the fact that the targeted investment in the RAP program cost a fraction of many quality improvement initiatives.
| Program leadership from operations and research
The RAP Steering Committee that reviewed and selected projects for funding consisted of researchers, clinical leadership, and operational leads; DOR scientists make up a minority of the committee's members.
By ensuring that organizational leaders who understood the KPNC health care objectives and strategies were a key part of the decisionmaking process, the RAP has been able to successfully solicit, select, and fund high priority rapid analysis projects. In addition, this partnership at the steering committee level served to model the research and operational collaborations that the RAP was designed to encourage, and helped to build trust and reputation across a number of clinical and scientific areas that were of strategic priority to the organization.
We recommend that health care delivery systems interested in developing a RAP-type program begin with this high level of collaboration in designing and implementing the program itself.
| Adhere to the principles of learning health system
Learning health systems seek to leverage their data systems, clinical knowledge, and experience toward improving health care for all of their patients. 16 A critical component of the success of the RAP is that it is embedded within a care delivery system that is committed to these principles, and eager to translate findings into action. In order for a program like RAP to succeed, an organization has to be invested in learning from project findings and in following through on both implementing and de-implementing strategies based on the results.
We believe rapid analytic partnerships can not only thrive within learning health care systems but also increase the capacity of the system to learn and grow. 
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